A nonrandomized open-label phase 2 trial of nonischemic heart preservation for human heart transplantation

Pre-clinical heart transplantation studies have shown that ex vivo non-ischemic heart preservation (NIHP) can be safely used for 24 h. Here we perform a prospective, open-label, non-randomized phase II study comparing NIHP to static cold preservation (SCS), the current standard for adult heart trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilsson, Johan, Jernryd, Victoria, Qin, Guangqi, Paskevicius, Audrius, Metzsch, Carsten, Sjöberg, Trygve, Steen, Stig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293246/
https://www.ncbi.nlm.nih.gov/pubmed/32532991
http://dx.doi.org/10.1038/s41467-020-16782-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293246/
https://www.ncbi.nlm.nih.gov/pubmed/32532991
http://dx.doi.org/10.1038/s41467-020-16782-9

Ejemplares similares